Raymond James Financial Services Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $341K | Sell |
10,362
-2,664
| -20% | -$87.6K | ﹤0.01% | 2881 |
|
|
2024
Q2 | $354K | Sell |
13,026
-37,924
| -74% | -$1.03M | ﹤0.01% | 2769 |
|
|
2024
Q1 | $1.85M | Buy |
50,950
+7,131
| +16% | +$259K | ﹤0.01% | 1674 |
|
|
2023
Q4 | $887K | Buy |
43,819
+13,162
| +43% | +$267K | ﹤0.01% | 2051 |
|
|
2023
Q3 | $545K | Buy |
30,657
+13,801
| +82% | +$245K | ﹤0.01% | 2268 |
|
|
2023
Q2 | $305K | Buy |
+16,856
| New | +$305K | ﹤0.01% | 2652 |
|